Eyes on New Product Development : Regulations, Generics, and Disruptive Technologies
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics - 37(2021), 4 vom: 18. Mai, Seite 191-192 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Novack, Gary D [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-Bacterial Agents |
|---|
| Anmerkungen: |
Date Completed 09.11.2021 Date Revised 09.11.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1089/jop.2021.29079.gdn |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM323173004 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM323173004 | ||
| 003 | DE-627 | ||
| 005 | 20231225183615.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1089/jop.2021.29079.gdn |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1077.xml |
| 035 | |a (DE-627)NLM323173004 | ||
| 035 | |a (NLM)33761283 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Novack, Gary D |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Eyes on New Product Development |b Regulations, Generics, and Disruptive Technologies |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.11.2021 | ||
| 500 | |a Date Revised 09.11.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Biological Products |2 NLM | |
| 650 | 7 | |a Drugs, Generic |2 NLM | |
| 650 | 7 | |a Ophthalmic Solutions |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics |d 1998 |g 37(2021), 4 vom: 18. Mai, Seite 191-192 |w (DE-627)NLM085101974 |x 1557-7732 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2021 |g number:4 |g day:18 |g month:05 |g pages:191-192 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1089/jop.2021.29079.gdn |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2021 |e 4 |b 18 |c 05 |h 191-192 | ||